Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_NSAID_OTHER
Extra metadata
List of similar endpoints to
Oter anti-inflammatory and antirheumatic agents, non-steroids
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 21427 | 14826 | 6601 |
| Unadjusted prevalence (%) | 8.24 | 10.09 | 5.84 |
| Mean age at first event (years) | 55.64 | 55.25 | 56.51 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.02 | 1.01 [0.88, 1.17] | 8.6e-1 | 2070 |
| 15 years | 0.01 | 1.13 [0.99, 1.28] | 6.3e-2 | 1629 |
| 5 years | 0.00 | 1.05 [0.91, 1.22] | 5.0e-1 | 308 |
| 1 year | 0.00 | 0.64 [0.44, 0.93] | 1.9e-2 | 32 |
Index endpoint: RX_NSAID_OTHER – Oter anti-inflammatory and antirheumatic agents, non-steroids
GWS hits:
before Oter anti-inflammatory and antirheumatic agents, non-steroids
after Oter anti-inflammatory and antirheumatic agents, non-steroids
Loading survival analyses plot
Loading survival analyses table